Streamlined Genetic Testing in Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

November 1, 2021

Conditions
Prostate Cancer
Interventions
BEHAVIORAL

Proactive Streamlined Genetic Education and Testing

This intervention consists of the proactive delivery of genetic education print materials followed by streamlined and facilitated access to genetic testing.

BEHAVIORAL

Usual Care

This intervention consists of a standard genetic referral letter that notified the participant that he qualified for genetic referral, recommends the scheduling of a genetic counseling session and provides a telephone number for scheduling.

Trial Locations (1)

20007

Georgetown University Medical Center/Lombardi Comprehensive Cancer Center, Washington D.C.

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Georgetown University

OTHER

NCT04359758 - Streamlined Genetic Testing in Prostate Cancer | Biotech Hunter | Biotech Hunter